A Study on Suicidality, Psychosis or Substance Abuse With Methylphenidate, Atomoxetine, Amphetamine/Dextroamphetamine or Lisdexamfetamine

Clinical trial NCT04132557 · COMPLETED

Trial details

NCT number: NCT04132557
Sponsor: Janssen Research & Development, LLC
Status: COMPLETED
Study type: OBSERVATIONAL

Attention Deficit Disorder With Hyperactivity

Start date: 2019-10-09
Primary completion: 2019-10-25
Enrollment: 430000

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.